Tranylcypromine · more major-labeled pairs than Dopamine
SPL labels Dopamine + Tranylcypromine as moderate; Dopamine 5 / Tranylcypromine 23 in that band.
Mechanism on file: Tranylcypromine prevents the body from breaking down dopamine, which can cause dopamine levels to become dangerously high. This can result in a life-threatening increase in blood pressure.
FDA SPL severity: Moderate
Dopamine + Tranylcypromine · SPL mechanism field
Tranylcypromine prevents the body from breaking down dopamine, which can cause dopamine levels to become dangerously high. This can result in a life-threatening increase in blood pressure.
Moderate band excerpt · Dopamine with Tranylcypromine
Product Clinical Comment on Concomitant Use [See Contraindications (4.1)] ; Predominant Effect/Risk [Hypertensive Reaction (HR) [See Warnings and Precautions (5.3)] ; or Serotonin Syndrome (SS) [See Warnings and Precautions (5.7)] ] Altretamine Use with caution If not otherwise specified in this table, consider avoiding concomitant use (see also information on medication-free intervals , use agent at the lowest appropriate dose, monitor for effects of the interaction, advise the patient to report potential effects, and be prepared to discontinue the agent and treat effects of the...
Dopamine · 5 moderate + 28 total pairs
- Carbidopa/Levodopa moderate
- Deutetrabenazine moderate
- Digoxin moderate
- Tetrabenazine moderate
Tranylcypromine · 7 major-labeled pairs (vs Dopamine's 0)
- Buspirone moderate
- Carbamazepine moderate
- Chlorpromazine moderate
- Cyclobenzaprine moderate
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.